NEW YORK and VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), is pleased to announce that all resolutions proposed to shareholders at the Annual and Special Meeting of Shareholders (the “Meeting”) held virtually via teleconference on January 18, 2022 were passed. Voting for each of the director nominees was as follows:
Checking box will enable automatic data updates
Briacell Therapeutics Corp(BCT-T)TSX
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
BriaCell Therapeutics Corp. Announces Results of 2022 Annual and Special Meeting of Shareholders
Globe Newswire - Wed Jan 19, 3:57PM CST